<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med</journal-id><journal-title>BMC Medicine</journal-title><issn pub-type="epub">1741-7015</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18078506</article-id><article-id pub-id-type="pmc">2249589</article-id><article-id pub-id-type="publisher-id">1741-7015-5-38</article-id><article-id pub-id-type="doi">10.1186/1741-7015-5-38</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Knee arthroscopy and exercise versus exercise only for chronic patellofemoral pain syndrome: a randomized controlled trial</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Kettunen</surname><given-names>Jyrki A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jyrki.kettunen@invalidisaatio.fi</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Harilainen</surname><given-names>Arsi</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>arsi.harilainen@invalidisaatio.fi</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Sandelin</surname><given-names>Jerker</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jerker.sandelin@invalidisaatio.fi</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Schlenzka</surname><given-names>Dietrich</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>dietrich.schlenzka@invalidisaatio.fi</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Hietaniemi</surname><given-names>Kalevi</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>kalevi.hietaniemi@hus.fi</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Seitsalo</surname><given-names>Seppo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>seppo.seitsalo@invalidisaatio.fi</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Malmivaara</surname><given-names>Antti</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>antti.malmivaara@stakes.fi</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Kujala</surname><given-names>Urho M</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>urho.kujala@sport.jyu.fi</email></contrib></contrib-group><aff id="I1"><label>1</label>The ORTON Research Institute, Invalid Foundation, Tenholantie 10, FIN-00280 Helsinki, Finland</aff><aff id="I2"><label>2</label>The ORTON Orthopaedic Hospital, Invalid Foundation, Tenholantie 10 FIN-00280 Helsinki, Finland</aff><aff id="I3"><label>3</label>The Helsinki University Central Hospital, Jorvi Hospital, Turuntie 150, FIN-02740 Espoo, Finland</aff><aff id="I4"><label>4</label>The Finnish Office for Health Care Technology Assessment/National Research and Development Centre for Welfare and Health, Lintulahdenkuja 4, FIN-00530 Helsinki, Finland</aff><aff id="I5"><label>5</label>The Department of Health Sciences, University of Jyväskylä, P.O. Box 35, FIN-40014 University of Jyväskylä, Finland</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2007</year></pub-date><volume>5</volume><fpage>38</fpage><lpage>38</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/5/38"></ext-link><history><date date-type="received"><day>27</day><month>4</month><year>2007</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2007</year></date></history><permissions><copyright-statement>Copyright © 2007 Kettunen et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Kettunen et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="4493" xml_f="4503" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4514" xml_f="4750" txt_i="22" txt_f="258">Arthroscopy is often used to treat patients with chronic patellofemoral pain syndrome (PFPS). As there is a lack of evidence, we conducted a randomized controlled trial to study the efficacy of arthroscopy in patients with chronic PFPS.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4791" xml_f="4798" txt_i="260" txt_f="267">Methods</offsets></title><p><offsets xml_i="4809" xml_f="4896" txt_i="268" txt_f="355">A total of 56 patients with chronic PFPS were randomized into two treatment groups: an </offsets><italic><offsets xml_i="4904" xml_f="4922" txt_i="355" txt_f="373">arthroscopy group </offsets></italic><offsets xml_i="4931" xml_f="4932" txt_i="373" txt_f="374">(</offsets><italic><offsets xml_i="4940" xml_f="4942" txt_i="374" txt_f="376">N </offsets></italic><offsets xml_i="4951" xml_f="5031" txt_i="376" txt_f="456">= 28), treated with knee arthroscopy and an 8-week home exercise program, and a </offsets><italic><offsets xml_i="5039" xml_f="5053" txt_i="456" txt_f="470">control group </offsets></italic><offsets xml_i="5062" xml_f="5063" txt_i="470" txt_f="471">(</offsets><italic><offsets xml_i="5071" xml_f="5073" txt_i="471" txt_f="473">N </offsets></italic><offsets xml_i="5082" xml_f="5490" txt_i="473" txt_f="881">= 28), treated with the 8-week home exercise program only. The arthroscopy included finding-specific surgical procedures according to current recommendations. The primary outcome was the Kujala score on patellofemoral pain and function at 9 months following randomization. Secondary outcomes were visual analog scales (VASs) to assess activity-related symptoms. We also estimated the direct healthcare costs.</offsets></p></sec><sec><title><offsets xml_i="5512" xml_f="5519" txt_i="883" txt_f="890">Results</offsets></title><p><offsets xml_i="5530" xml_f="6057" txt_i="891" txt_f="1418">Both groups showed marked improvement during the follow-up. The mean improvement in the Kujala score was 12.9 (95% confidence interval (CI) 8.2–17.6) in the arthroscopy group and 11.4 (95% CI 6.9–15.8) in the control group. However, there was no difference between the groups in mean improvement in the Kujala score (group difference 1.1 (95% CI -7.4 - 5.2)) or in any of the VAS scores. Total direct healthcare costs in the arthroscopy group were estimated to exceed on average those of the control group by €901 per patient (</offsets><italic><offsets xml_i="6065" xml_f="6067" txt_i="1418" txt_f="1420">p </offsets></italic><offsets xml_i="6076" xml_f="6088" txt_i="1420" txt_f="1429">&lt; 0.001).</offsets></p></sec><sec><title><offsets xml_i="6110" xml_f="6120" txt_i="1431" txt_f="1441">Conclusion</offsets></title><p><offsets xml_i="6131" xml_f="6336" txt_i="1442" txt_f="1647">In this controlled trial involving patients with chronic PFPS, the outcome when arthroscopy was used in addition to a home exercise program was no better than when the home exercise program was used alone.</offsets></p></sec><sec><title><offsets xml_i="6358" xml_f="6376" txt_i="1649" txt_f="1667">Trial registration</offsets></title><p><offsets xml_i="6387" xml_f="6428" txt_i="1668" txt_f="1709">Current Controlled Trials ISRCTN 41800323</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="6490" xml_f="6500" txt_i="1718" txt_f="1728">Background</offsets></title><p><offsets xml_i="6511" xml_f="6616" txt_i="1729" txt_f="1834">Patellofemoral pain syndrome (PFPS) is a common problem and has an impact on many aspects of daily life [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6647" xml_f="6648" txt_i="1834" txt_f="1835">1</offsets></xref><offsets xml_i="6655" xml_f="6656" txt_i="1835" txt_f="1836">,</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6687" xml_f="6688" txt_i="1836" txt_f="1837">2</offsets></xref><offsets xml_i="6695" xml_f="6872" txt_i="1837" txt_f="2014">]. The possibly multifactorial etiology of PFPS is partially unknown and a wide range of conservative and surgical procedures has been used to treat patients with the syndrome [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6903" xml_f="6904" txt_i="2014" txt_f="2015">3</offsets></xref><offsets xml_i="6911" xml_f="6913" txt_i="2015" txt_f="2017">].</offsets></p><p><offsets xml_i="6920" xml_f="7015" txt_i="2018" txt_f="2113">There is some evidence that exercise therapy reduces anterior knee pain in patients with PFPS [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7046" xml_f="7047" txt_i="2113" txt_f="2114">4</offsets></xref><offsets xml_i="7054" xml_f="7394" txt_i="2114" txt_f="2454">]. Although many physicians prefer conservative therapy modalities in the treatment of PFPS with unknown origin of pain, in chronic cases and after the failure of conservative treatment, arthroscopy is often carried out. However, although a few randomized controlled trials (RCTs) have compared the effects of various operative techniques [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7425" xml_f="7426" txt_i="2454" txt_f="2455">5</offsets></xref><offsets xml_i="7433" xml_f="7434" txt_i="2455" txt_f="2456">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7465" xml_f="7466" txt_i="2456" txt_f="2457">6</offsets></xref><offsets xml_i="7473" xml_f="7756" txt_i="2457" txt_f="2740">], no RCTs either analyzing the diagnostic value of arthroscopy or comparing surgical interventions with conservative therapy in the treatment of PFPS have been published. Surgical interventions in PFPS should be based on diagnostic findings suspected to underlie the pain syndrome [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="7787" xml_f="7788" txt_i="2740" txt_f="2741">2</offsets></xref><offsets xml_i="7795" xml_f="8195" txt_i="2741" txt_f="3141">]. Arthroscopy is used to make a specific diagnosis and to perform finding-specific surgical procedures. To further clarify the additional value of diagnostic and operative arthroscopy, we conducted a randomized trial to assess the efficacy of arthroscopy in conjunction with a home exercise program (arthroscopy group) versus home exercise program only (control group) in patients with chronic PFPS.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="8236" xml_f="8243" txt_i="3143" txt_f="3150">Methods</offsets></title><sec><title><offsets xml_i="8263" xml_f="8281" txt_i="3151" txt_f="3169">Study participants</offsets></title><p><offsets xml_i="8292" xml_f="8802" txt_i="3170" txt_f="3680">Orthopedic surgeons identified consecutive female or male PFPS patients who had been admitted to either the ORTON Orthopaedic Hospital, Helsinki, or one of the outpatient clinics of the public hospitals of the Hospital District of Helsinki and Uusimaa between May 2003 and February 2005. According to our study protocol 56 patients were needed to detect a clinically significant difference between the outcomes of the groups studied. All of the patients who fulfilled the first-stage selection criteria (Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="8834" xml_f="8835" txt_i="3680" txt_f="3681">1</offsets></xref><offsets xml_i="8842" xml_f="9255" txt_i="3681" txt_f="4094">) and gave their preliminary consent to participate in the study attended a structured clinical interview and examination held in the ORTON Orthopaedic Hospital and carried out by an experienced orthopedic surgeon (DS) who was not involved in the treatment of these patients. The patients also answered a structured questionnaire. If the patient did not fulfill the final (second stage) inclusion criteria (Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="9287" xml_f="9288" txt_i="4094" txt_f="4095">1</offsets></xref><offsets xml_i="9295" xml_f="9934" txt_i="4095" txt_f="4734">) they were excluded. On the basis of the orthopedic surgeon's examination and knee X-ray findings four patients did not fulfill the final inclusion criteria and were excluded from the study. Three of them had symptoms and signs of meniscal injury and one patient had a disabling general illness. Furthermore, one patient refused to participate before randomization. Among patients with bilateral knee symptoms, the knee with the more severe symptoms was included in the study. All of the 56 patients who fulfilled the final inclusion criteria signed an informed consent immediately after the clinical examination and before randomization.</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="9982" xml_f="9989" txt_i="4735" txt_f="4742">Table 1</offsets></label><caption><p><offsets xml_i="10009" xml_f="10066" txt_i="4742" txt_f="4799">Inclusion and exclusion criteria among patients with PFPS</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" colspan="2"><offsets xml_i="10157" xml_f="10293" txt_i="4800" txt_f="4936">The first stage (evaluation in the ORTON Orthopaedic Hospital or in the outpatient clinics of the public hospitals in the Helsinki area)</offsets></td></tr><tr><td align="left"><offsets xml_i="10324" xml_f="10342" txt_i="4937" txt_f="4955">Inclusion criteria</offsets></td><td align="left"><offsets xml_i="10364" xml_f="10382" txt_i="4956" txt_f="4974">Exclusion criteria</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="10428" xml_f="10445" txt_i="4975" txt_f="4992">Age 18 – 40 years</offsets></td><td align="left"><offsets xml_i="10467" xml_f="10492" txt_i="4993" txt_f="5018">Disabling general illness</offsets></td></tr><tr><td align="left"><offsets xml_i="10523" xml_f="10537" txt_i="5019" txt_f="5033">Female or male</offsets></td><td align="left"><offsets xml_i="10559" xml_f="10605" txt_i="5034" txt_f="5080">Reported knee ligamentous or meniscal injuries</offsets></td></tr><tr><td align="left"><offsets xml_i="10636" xml_f="10705" txt_i="5081" txt_f="5150">Characteristic history of PFPS and symptoms lasting at least 6 months</offsets></td><td align="left"><offsets xml_i="10727" xml_f="10748" txt_i="5151" txt_f="5172">Previous knee surgery</offsets></td></tr><tr><td align="left"><offsets xml_i="10779" xml_f="10901" txt_i="5173" txt_f="5295">Patellofemoral pain during knee loading physical activity, such as jumping, running, squatting, or going up or down stairs</offsets></td><td align="left"><offsets xml_i="10923" xml_f="10962" txt_i="5296" txt_f="5335">Physician diagnosed knee osteoarthritis</offsets></td></tr><tr><td align="left"><offsets xml_i="10993" xml_f="11095" txt_i="5336" txt_f="5438">Patellofemoral pain when the knee was kept in flexion for a prolonged period, with relief on extension</offsets></td><td align="left"><offsets xml_i="11117" xml_f="11221" txt_i="5439" txt_f="5543">A history of patellar dislocation; however, subjects with patellar subluxation are included in the study</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="11261" xml_f="11335" txt_i="5545" txt_f="5619">Other knee problems than PFPS diagnosed clinically (such as jumper's knee)</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="11375" xml_f="11467" txt_i="5621" txt_f="5713">Other knee problems than PFPS diagnosed radiographically (such as osteochondritis dissecans)</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="11507" xml_f="11560" txt_i="5715" txt_f="5768">Physical therapy for PFPS within the previous 4 weeks</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="11600" xml_f="11609" txt_i="5770" txt_f="5779">Pregnancy</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="11649" xml_f="11668" txt_i="5781" txt_f="5800">Competitive athlete</offsets></td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left" colspan="2"><offsets xml_i="11750" xml_f="11835" txt_i="5802" txt_f="5887">The second stage (orthopedic surgeon's clinical and radiological evaluation in ORTON)</offsets></td></tr><tr><td align="left"><offsets xml_i="11866" xml_f="11884" txt_i="5888" txt_f="5906">Inclusion criteria</offsets></td><td align="left"><offsets xml_i="11906" xml_f="11924" txt_i="5907" txt_f="5925">Exclusion criteria</offsets></td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left"><offsets xml_i="11994" xml_f="12009" txt_i="5927" txt_f="5942">As in stage one</offsets></td><td align="left"><offsets xml_i="12031" xml_f="12096" txt_i="5943" txt_f="6008">Clear medio-lateral instability in manual instability measurement</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="12136" xml_f="12165" txt_i="6010" txt_f="6039">Knee problems other than PFPS</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="12205" xml_f="12224" txt_i="6041" txt_f="6060">Knee osteoarthritis</offsets></td></tr><tr><td></td><td align="left"><offsets xml_i="12264" xml_f="12349" txt_i="6062" txt_f="6147">Osteochondritis dissecans, loose bodies in the patellofemoral and tibiofemoral joints</offsets></td></tr></tbody></table></table-wrap></sec><sec><title><offsets xml_i="12406" xml_f="12448" txt_i="6149" txt_f="6191">Randomization process and treatment groups</offsets></title><p><offsets xml_i="12459" xml_f="12518" txt_i="6192" txt_f="6251">The patients were randomized into two treatment groups: an </offsets><italic><offsets xml_i="12526" xml_f="12543" txt_i="6251" txt_f="6268">arthroscopy group</offsets></italic><offsets xml_i="12552" xml_f="12634" txt_i="6268" txt_f="6350">, which was treated with knee arthroscopy and 8-week home exercise program, and a </offsets><italic><offsets xml_i="12642" xml_f="12655" txt_i="6350" txt_f="6363">control group</offsets></italic><offsets xml_i="12664" xml_f="12740" txt_i="6363" txt_f="6439">, which was treated with the same 8-week home exercise program only (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="12770" xml_f="12771" txt_i="6439" txt_f="6440">1</offsets></xref><offsets xml_i="12778" xml_f="13149" txt_i="6440" txt_f="6811">). The randomization process was carried out using a computer-generated randomization list stratified by gender. Sealed, sequentially numbered envelopes containing information on the treatment group were prepared and given to the assisting nurse, who opened the envelopes in numerical order after recruitment so that concealment of allocation was successful in all cases.</offsets></p><fig position="float" id="F1"><label><offsets xml_i="13190" xml_f="13198" txt_i="6812" txt_f="6820">Figure 1</offsets></label><caption><p><offsets xml_i="13218" xml_f="13232" txt_i="6820" txt_f="6834">Trial profile.</offsets></p></caption><graphic xlink:href="1741-7015-5-38-1"></graphic></fig></sec><sec><title><offsets xml_i="13319" xml_f="13336" txt_i="6836" txt_f="6853">Exercise protocol</offsets></title><p><offsets xml_i="13347" xml_f="13401" txt_i="6854" txt_f="6908">The 8-week home exercise program (see Additional File </offsets><xref ref-type="supplementary-material" rid="S1"><offsets xml_i="13450" xml_f="13451" txt_i="6908" txt_f="6909">1</offsets></xref><offsets xml_i="13458" xml_f="14308" txt_i="6909" txt_f="7759">) was started 3 weeks after randomization in all patients (2 weeks after arthroscopy in the arthroscopy group). At the first visit an experienced physiotherapist gave instruction individually on lower-limb muscle strengthening and stretching exercises to be performed daily during the first four weeks at home. The approximate duration of each session was 30 min. The second visit was during the third week from the beginning of the exercise period. For the resisted knee extension and flexion exercises in the second part of the program, all of the patients were given a rubber sling to be used around the ankle. Again, the patients were instructed to repeat the prescribed exercises daily. They were instructed to avoid symptom-producing activities during the intervention. The duration of each daily home exercise session was approximately 30 min.</offsets></p></sec><sec><title><offsets xml_i="14330" xml_f="14341" txt_i="7761" txt_f="7772">Arthroscopy</offsets></title><p><offsets xml_i="14352" xml_f="14844" txt_i="7773" txt_f="8265">All of the patients who were randomized into the arthroscopy group received arthroscopy; however, one of them refused to continue treatment thereafter. Arthroscopy was performed one week after randomization by one of the two experienced knee orthopedic surgeons (AH, JS). All of the knee compartments were examined systematically and pathological findings were recorded. The stage of cartilage lesions in the patellofemoral joint was recorded on a standard form according to the Outerbridge [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="14875" xml_f="14876" txt_i="8265" txt_f="8266">7</offsets></xref><offsets xml_i="14883" xml_f="15115" txt_i="8266" txt_f="8498">] classification. During arthroscopy the following procedures were performed, if justified on the basis of the arthroscopic findings and according to our pre-determined guidelines, which followed generally accepted recommendations [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="15146" xml_f="15147" txt_i="8498" txt_f="8499">2</offsets></xref><offsets xml_i="15154" xml_f="15792" txt_i="8499" txt_f="9137">]: resection of inflamed/scarred medial plicae, abrasion of chondral lesions and shaving of excessive and inflamed synovium. Minor corrections of the patellofemoral articulation were performed, such as lateral capsular discision in the case of clear lateral patellar subluxation in the beginning of knee flexion. Moreover, possible meniscal tears were treated. These patients remained in the study group and they participated in the standardized training protocol. One patient, however, was unable to start the exercise program at 2 weeks following the arthroscopy because of pain, and the start of her training was adjusted individually.</offsets></p></sec><sec><title><offsets xml_i="15814" xml_f="15830" txt_i="9139" txt_f="9155">Outcome measures</offsets></title><p><offsets xml_i="15841" xml_f="16692" txt_i="9156" txt_f="10007">Outcome measures were collected using self-administered questionnaires. This data collection was organized by the study coordinator (JAK). As the coordinator did not have any presuppositions as to which of the groups would show better results and because he was not a treatment provider, the data collector was not, for practical reasons, blinded to the treatment groups. The measurements were completed before randomization, immediately after the end of home training period and 9 months after randomization. At each time point the patients filled in the questionnaire alone in a quiet room. The patient-completed questionnaire was then checked by the study coordinator and missing items, if any, were answered. The 24-month evaluation was conducted using a postal questionnaire. The primary outcome measure was the Kujala score (see Additional File </offsets><xref ref-type="supplementary-material" rid="S2"><offsets xml_i="16741" xml_f="16742" txt_i="10007" txt_f="10008">2</offsets></xref><offsets xml_i="16749" xml_f="16752" txt_i="10008" txt_f="10011">) [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="16783" xml_f="16784" txt_i="10011" txt_f="10012">8</offsets></xref><offsets xml_i="16791" xml_f="16838" txt_i="10012" txt_f="10059">], also known as the anterior knee pain score [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="16869" xml_f="16870" txt_i="10059" txt_f="10060">9</offsets></xref><offsets xml_i="16877" xml_f="17276" txt_i="10060" txt_f="10459">], which is a 13-item questionnaire including different items on pain related to functioning and activities. The categories within each item are weighted and item scores summed to provide an overall index scored from 0 to 100 where the maximum score of 100 represents no disability. Other investigators have shown that the questionnaire is a reliable, valid and responsive outcome measure for PFPS [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="17307" xml_f="17308" txt_i="10459" txt_f="10460">9</offsets></xref><offsets xml_i="17315" xml_f="17403" txt_i="10460" txt_f="10548">], patients have described it as easy to understand and as depicting the symptoms well [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="17435" xml_f="17437" txt_i="10548" txt_f="10550">10</offsets></xref><offsets xml_i="17444" xml_f="17573" txt_i="10550" txt_f="10679">], and the score has been used widely in evaluating patellofemoral disorders in scientific studies. According to Crossley et al [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="17604" xml_f="17605" txt_i="10679" txt_f="10680">9</offsets></xref><offsets xml_i="17612" xml_f="17743" txt_i="10680" txt_f="10811">] a clinically significant improvement is deemed to have occurred when the patient's score shows an increase of around 8–10 points.</offsets></p><p><offsets xml_i="17750" xml_f="18402" txt_i="10812" txt_f="11464">As secondary outcome measures we used three 10-cm visual analog scales (VASs) to assess activity-related pain. Participants assessed the maximum pain they had felt during the previous 2 days when ascending stairs, descending stairs and standing up from a sitting position. Also, a global rating of change between baseline and follow-up (overall assessment) was evaluated with an additional six-point scale: 1, asymptomatic knee, to 6, marked worsening. The scale was later dichotomized and analyzed as follows: (1) marked worsening, moderate worsening or no change from baseline versus (2) moderate improvement, marked improvement or asymptomatic knee.</offsets></p></sec><sec><title><offsets xml_i="18424" xml_f="18429" txt_i="11466" txt_f="11471">Diary</offsets></title><p><offsets xml_i="18440" xml_f="18865" txt_i="11472" txt_f="11897">The patients kept a diary during the therapy intervention. The patients calculated the weekly frequency with which they had followed the exercise protocol. The diary also included questions on pain and discomfort (VAS), possible complications and use of drugs as well as other healthcare services and treatments not related to the study protocol. The patients were advised to avoid other therapies during the exercise period.</offsets></p></sec><sec><title><offsets xml_i="18887" xml_f="18906" txt_i="11899" txt_f="11918">Economic evaluation</offsets></title><p><offsets xml_i="18917" xml_f="19114" txt_i="11919" txt_f="12116">Direct healthcare costs included the baseline orthopedic surgeon's visit, the costs of the interventions and additional visits to healthcare providers during the intervention and follow-up period [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="19146" xml_f="19148" txt_i="12116" txt_f="12118">11</offsets></xref><offsets xml_i="19155" xml_f="19157" txt_i="12118" txt_f="12120">].</offsets></p></sec><sec><title><offsets xml_i="19179" xml_f="19192" txt_i="12122" txt_f="12135">Data analysis</offsets></title><p><offsets xml_i="19203" xml_f="19528" txt_i="12136" txt_f="12461">The statistical analysis was done with Statistical Package for the Social Sciences 15.0 (Norusis/SPSS, Inc., Chicago, IL). The sample size was calculated to detect a mean difference of 10 points in the Kujala score between the treatment groups, using a standard deviation of 13 determined on the basis of our pilot material [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="19560" xml_f="19562" txt_i="12461" txt_f="12463">12</offsets></xref><offsets xml_i="19569" xml_f="19753" txt_i="12463" txt_f="12647">]. To obtain a less than 5% probability of a type-I error and a power of 80%, 27 participants were required in each group. We randomized 56 patients, allocating 28 to each study group.</offsets></p><p><offsets xml_i="19760" xml_f="20269" txt_i="12648" txt_f="13157">The primary analysis was intention-to-treat and the primary follow-up time was 9 months from randomization. Comparisons between the groups were performed with analysis of covariance using the baseline scores as a covariate. The secondary follow-up time was 24 months from randomization. In addition, we carried out 'a worst-case scenario' analysis of the data. In this analysis, we assumed that the Kujala score would have been the same as the baseline score (no change), if follow-up data were not available.</offsets></p></sec><sec><title><offsets xml_i="20291" xml_f="20307" txt_i="13159" txt_f="13175">Ethical approval</offsets></title><p><offsets xml_i="20318" xml_f="20472" txt_i="13176" txt_f="13330">The ethical committee of the Hospital District of Helsinki and Uusimaa and the review board of the ORTON Orthopaedic Hospital approved the study protocol.</offsets></p></sec></sec><sec><title><offsets xml_i="20500" xml_f="20507" txt_i="13333" txt_f="13340">Results</offsets></title><p><offsets xml_i="20518" xml_f="20569" txt_i="13341" txt_f="13392">Fifty-six patients underwent randomization (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="20599" xml_f="20600" txt_i="13392" txt_f="13393">1</offsets></xref><offsets xml_i="20607" xml_f="20678" txt_i="13393" txt_f="13464">). The baseline characteristics were similar between the groups (Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="20710" xml_f="20711" txt_i="13464" txt_f="13465">2</offsets></xref><offsets xml_i="20718" xml_f="20985" txt_i="13465" txt_f="13732">). Also, no group difference was observed in the reported work-related physical loading at baseline. Compliance with the training protocol was similar in both study groups: mean weekly exercise frequency was 5.0 in the arthroscopy group and 5.2 in the control group (</offsets><italic><offsets xml_i="20993" xml_f="20995" txt_i="13732" txt_f="13734">p </offsets></italic><offsets xml_i="21004" xml_f="21012" txt_i="13734" txt_f="13742">= 0.52).</offsets></p><table-wrap position="float" id="T2"><label><offsets xml_i="21060" xml_f="21067" txt_i="13743" txt_f="13750">Table 2</offsets></label><caption><p><offsets xml_i="21087" xml_f="21138" txt_i="13750" txt_f="13801">Baseline characteristics of the randomized patients</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><offsets xml_i="21226" xml_f="21245" txt_i="13803" txt_f="13822">Arthroscopy group (</offsets><italic><offsets xml_i="21253" xml_f="21255" txt_i="13822" txt_f="13824">N </offsets></italic><offsets xml_i="21264" xml_f="21269" txt_i="13824" txt_f="13829">= 28)</offsets></td><td align="left"><offsets xml_i="21291" xml_f="21306" txt_i="13830" txt_f="13845">Control group (</offsets><italic><offsets xml_i="21314" xml_f="21316" txt_i="13845" txt_f="13847">N </offsets></italic><offsets xml_i="21325" xml_f="21330" txt_i="13847" txt_f="13852">= 28)</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="21376" xml_f="21391" txt_i="13853" txt_f="13868">Characteristics</offsets></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="21440" xml_f="21450" txt_i="13871" txt_f="13881">Age, years</offsets></td><td align="left"><offsets xml_i="21472" xml_f="21482" txt_i="13882" txt_f="13892">28.4 (7.5)</offsets></td><td align="left"><offsets xml_i="21504" xml_f="21514" txt_i="13893" txt_f="13903">28.4 (5.6)</offsets></td></tr><tr><td align="left"><offsets xml_i="21545" xml_f="21555" txt_i="13904" txt_f="13914">Female % (</offsets><italic><offsets xml_i="21563" xml_f="21564" txt_i="13914" txt_f="13915">N</offsets></italic><offsets xml_i="21573" xml_f="21574" txt_i="13915" txt_f="13916">)</offsets></td><td align="left"><offsets xml_i="21596" xml_f="21605" txt_i="13917" txt_f="13926">60.7 (17)</offsets></td><td align="left"><offsets xml_i="21627" xml_f="21636" txt_i="13927" txt_f="13936">64.3 (18)</offsets></td></tr><tr><td align="left"><offsets xml_i="21667" xml_f="21677" txt_i="13937" txt_f="13947">Height, cm</offsets></td><td align="left"><offsets xml_i="21699" xml_f="21711" txt_i="13948" txt_f="13960">171.7 (10.2)</offsets></td><td align="left"><offsets xml_i="21733" xml_f="21744" txt_i="13961" txt_f="13972">172.4 (9.6)</offsets></td></tr><tr><td align="left"><offsets xml_i="21775" xml_f="21785" txt_i="13973" txt_f="13983">Weight, kg</offsets></td><td align="left"><offsets xml_i="21807" xml_f="21818" txt_i="13984" txt_f="13995">69.0 (19.3)</offsets></td><td align="left"><offsets xml_i="21840" xml_f="21851" txt_i="13996" txt_f="14007">71.4 (15.1)</offsets></td></tr><tr><td align="left"><offsets xml_i="21882" xml_f="21891" txt_i="14008" txt_f="14017">BMI, kg m</offsets><sup><offsets xml_i="21896" xml_f="21898" txt_i="14017" txt_f="14019">-2</offsets></sup></td><td align="left"><offsets xml_i="21926" xml_f="21936" txt_i="14020" txt_f="14030">24.1 (3.3)</offsets></td><td align="left"><offsets xml_i="21958" xml_f="21968" txt_i="14031" txt_f="14041">23.8 (3.6)</offsets></td></tr><tr><td align="left"><offsets xml_i="21999" xml_f="22027" txt_i="14042" txt_f="14070">Duration of symptoms, months</offsets></td><td align="left"><offsets xml_i="22049" xml_f="22060" txt_i="14071" txt_f="14082">54.9 (73.4)</offsets></td><td align="left"><offsets xml_i="22082" xml_f="22093" txt_i="14083" txt_f="14094">45.0 (74.9)</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="22139" xml_f="22210" txt_i="14095" txt_f="14166">There were no statistically significant differences between the groups.</offsets></p><p><offsets xml_i="22217" xml_f="22249" txt_i="14167" txt_f="14199">Data are mean (SD) or per cent (</offsets><italic><offsets xml_i="22257" xml_f="22258" txt_i="14199" txt_f="14200">N</offsets></italic><offsets xml_i="22267" xml_f="22269" txt_i="14200" txt_f="14202">).</offsets></p></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="22322" xml_f="22342" txt_i="14204" txt_f="14224">Nine-month follow-up</offsets></title><p><offsets xml_i="22353" xml_f="22456" txt_i="14225" txt_f="14328">One patient in the arthroscopy group and three in the control group were lost to the follow-up (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="22486" xml_f="22487" txt_i="14328" txt_f="14329">1</offsets></xref><offsets xml_i="22494" xml_f="22724" txt_i="14329" txt_f="14559">). In the arthroscopy group 37% (10/27) and in the control group 20% (5/25) of the patients reported that they had used oral anti-inflammatory analgesics during the follow-up, either during the home training period or afterwards (</offsets><italic><offsets xml_i="22732" xml_f="22734" txt_i="14559" txt_f="14561">p </offsets></italic><offsets xml_i="22743" xml_f="22751" txt_i="14561" txt_f="14569">= 0.23).</offsets></p><p><offsets xml_i="22758" xml_f="23304" txt_i="14570" txt_f="15116">Three patients in the control group insisted on having an arthroscopy after the exercise intervention and prior to the 9-month follow-up. The arthroscopy findings of these patients were normal knee, softening of the patellar cartilage and marginal medial meniscus rupture. These patients participated in the follow-up and were analyzed according to their original group assignment. The absolute changes in the Kujala score in these patients were 7, 13 and -4, while among the remaining patients in the control group the mean improvement was 12.7.</offsets></p><p><offsets xml_i="23311" xml_f="23437" txt_i="15117" txt_f="15243">The mean improvement in the Kujala score between randomization and follow-up was 12.9 (95% confidence interval (CI) 8.2–17.6, </offsets><italic><offsets xml_i="23445" xml_f="23447" txt_i="15243" txt_f="15245">p </offsets></italic><offsets xml_i="23456" xml_f="23521" txt_i="15245" txt_f="15307">&lt; 0.001)) in the arthroscopy group and 11.4 (95% CI 6.9–15.8, </offsets><italic><offsets xml_i="23529" xml_f="23531" txt_i="15307" txt_f="15309">p </offsets></italic><offsets xml_i="23540" xml_f="23695" txt_i="15309" txt_f="15461">&lt; 0.001) in the control group. No difference between the two groups was observed in mean improvement according to the Kujala score or VAS scores (Table </offsets><xref ref-type="table" rid="T3"><offsets xml_i="23727" xml_f="23728" txt_i="15461" txt_f="15462">3</offsets></xref><offsets xml_i="23735" xml_f="23865" txt_i="15462" txt_f="15592">). Similar results were obtained from the 'worst-case scenario' analysis (mean difference in Kujala score 2.0; 95% CI -8.0 - 4.1, </offsets><italic><offsets xml_i="23873" xml_f="23875" txt_i="15592" txt_f="15594">p </offsets></italic><offsets xml_i="23884" xml_f="23894" txt_i="15594" txt_f="15604">= 0.523)).</offsets></p><table-wrap position="float" id="T3"><label><offsets xml_i="23942" xml_f="23949" txt_i="15605" txt_f="15612">Table 3</offsets></label><caption><p><offsets xml_i="23969" xml_f="24028" txt_i="15612" txt_f="15671">Results of intention-to-treat analysis of outcomes by group</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="2"><offsets xml_i="24130" xml_f="24147" txt_i="15673" txt_f="15690">Arthroscopy group</offsets></td><td align="center" colspan="2"><offsets xml_i="24183" xml_f="24196" txt_i="15691" txt_f="15704">Control group</offsets></td><td></td></tr><tr><td></td><td align="left"><offsets xml_i="24245" xml_f="24256" txt_i="15707" txt_f="15718">At baseline</offsets></td><td align="left"><offsets xml_i="24278" xml_f="24295" txt_i="15719" txt_f="15736">9-month follow-up</offsets></td><td align="left"><offsets xml_i="24317" xml_f="24328" txt_i="15737" txt_f="15748">At baseline</offsets></td><td align="left"><offsets xml_i="24350" xml_f="24367" txt_i="15749" txt_f="15766">9-month follow-up</offsets></td><td align="left"><offsets xml_i="24389" xml_f="24430" txt_i="15767" txt_f="15808">Difference in mean change scores (95% CI)</offsets><sup><offsets xml_i="24435" xml_f="24438" txt_i="15808" txt_f="15811">1,2</offsets></sup></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="24490" xml_f="24513" txt_i="15812" txt_f="15835">Kujala score, mean (SD)</offsets></td><td align="left"><offsets xml_i="24535" xml_f="24546" txt_i="15836" txt_f="15847">69.0 (10.7)</offsets></td><td align="left"><offsets xml_i="24568" xml_f="24579" txt_i="15848" txt_f="15859">81.9 (14.1)</offsets></td><td align="left"><offsets xml_i="24601" xml_f="24612" txt_i="15860" txt_f="15871">71.1 (13.0)</offsets></td><td align="left"><offsets xml_i="24634" xml_f="24645" txt_i="15872" txt_f="15883">82.5 (15.3)</offsets></td><td align="left"><offsets xml_i="24667" xml_f="24684" txt_i="15884" txt_f="15901">1.1 (-7.4 to 5.2)</offsets></td></tr><tr><td align="left"><offsets xml_i="24715" xml_f="24757" txt_i="15902" txt_f="15944">Pain when descending stairs, VAS mean (SD)</offsets></td><td align="left"><offsets xml_i="24779" xml_f="24790" txt_i="15945" txt_f="15956">43.4 (27.2)</offsets></td><td align="left"><offsets xml_i="24812" xml_f="24823" txt_i="15957" txt_f="15968">21.1 (23.0)</offsets></td><td align="left"><offsets xml_i="24845" xml_f="24856" txt_i="15969" txt_f="15980">35.0 (26.9)</offsets></td><td align="left"><offsets xml_i="24878" xml_f="24889" txt_i="15981" txt_f="15992">18.0 (23.3)</offsets></td><td align="left"><offsets xml_i="24911" xml_f="24930" txt_i="15993" txt_f="16012">0.9 (-10.1 to 11.9)</offsets></td></tr><tr><td align="left"><offsets xml_i="24961" xml_f="25002" txt_i="16013" txt_f="16054">Pain when ascending stairs, VAS mean (SD)</offsets></td><td align="left"><offsets xml_i="25024" xml_f="25035" txt_i="16055" txt_f="16066">48.8 (29.9)</offsets></td><td align="left"><offsets xml_i="25057" xml_f="25068" txt_i="16067" txt_f="16078">20.9 (24.7)</offsets></td><td align="left"><offsets xml_i="25090" xml_f="25101" txt_i="16079" txt_f="16090">41.1 (29.4)</offsets></td><td align="left"><offsets xml_i="25123" xml_f="25134" txt_i="16091" txt_f="16102">20.5 (24.9)</offsets></td><td align="left"><offsets xml_i="25156" xml_f="25175" txt_i="16103" txt_f="16122">2.6 (-10.0 to 15.2)</offsets></td></tr><tr><td align="left"><offsets xml_i="25206" xml_f="25266" txt_i="16123" txt_f="16183">Pain when standing up from a sitting position, VAS mean (SD)</offsets></td><td align="left"><offsets xml_i="25288" xml_f="25299" txt_i="16184" txt_f="16195">39.0 (28.1)</offsets></td><td align="left"><offsets xml_i="25321" xml_f="25332" txt_i="16196" txt_f="16207">16.6 (22.4)</offsets></td><td align="left"><offsets xml_i="25354" xml_f="25365" txt_i="16208" txt_f="16219">41.4 (28.7)</offsets></td><td align="left"><offsets xml_i="25387" xml_f="25398" txt_i="16220" txt_f="16231">21.8 (25.3)</offsets></td><td align="left"><offsets xml_i="25420" xml_f="25438" txt_i="16232" txt_f="16250">4.1 (-7.0 to 15.2)</offsets></td></tr></tbody></table><table-wrap-foot><p><sup><offsets xml_i="25489" xml_f="25490" txt_i="16251" txt_f="16252">1</offsets></sup><offsets xml_i="25496" xml_f="25605" txt_i="16252" txt_f="16361">The difference is positive, when the mean change in score was greater for arthroscopy than for control group.</offsets></p><p><sup><offsets xml_i="25617" xml_f="25618" txt_i="16362" txt_f="16363">2</offsets></sup><offsets xml_i="25624" xml_f="25653" txt_i="16363" txt_f="16392">Adjusted for baseline values.</offsets></p></table-wrap-foot></table-wrap><p><offsets xml_i="25691" xml_f="25856" txt_i="16393" txt_f="16558">In the arthroscopy group 82% (22/27) and in the control group 76% (19/25) of the patients reported at least moderate improvement at the end of the follow-up period (</offsets><italic><offsets xml_i="25864" xml_f="25866" txt_i="16558" txt_f="16560">p </offsets></italic><offsets xml_i="25875" xml_f="26145" txt_i="16560" txt_f="16830">= 0.74). When the arthroscopy and control groups were combined, the mean change in the Kujala score among those patients who reported no improvement during the 9-month follow-up was 5.0 (SD 10.5) and among those with at least moderate improvement it was 14.1 (SD 10.8), </offsets><italic><offsets xml_i="26153" xml_f="26155" txt_i="16830" txt_f="16832">p </offsets></italic><offsets xml_i="26164" xml_f="26172" txt_i="16832" txt_f="16840">= 0.016.</offsets></p><sec><title><offsets xml_i="26188" xml_f="26220" txt_i="16841" txt_f="16873">Arthroscopy findings and outcome</offsets></title><p><offsets xml_i="26231" xml_f="26324" txt_i="16874" txt_f="16967">The arthroscopy findings and surgical procedures in the arthroscopy group are shown in Table </offsets><xref ref-type="table" rid="T4"><offsets xml_i="26356" xml_f="26357" txt_i="16967" txt_f="16968">4</offsets></xref><offsets xml_i="26364" xml_f="26502" txt_i="16968" txt_f="17106">. The Kujala score improved between randomization and follow-up in the arthroscopy group in those whose arthroscopy findings were normal (</offsets><italic><offsets xml_i="26510" xml_f="26512" txt_i="17106" txt_f="17108">N </offsets></italic><offsets xml_i="26521" xml_f="26611" txt_i="17108" txt_f="17198">= 5) by 17.0 points and in those with at least one abnormality documented at arthroscopy (</offsets><italic><offsets xml_i="26619" xml_f="26621" txt_i="17198" txt_f="17200">N </offsets></italic><offsets xml_i="26630" xml_f="26658" txt_i="17200" txt_f="17228">= 22) by 12.0 points (Table </offsets><xref ref-type="table" rid="T4"><offsets xml_i="26690" xml_f="26691" txt_i="17228" txt_f="17229">4</offsets></xref><offsets xml_i="26698" xml_f="26951" txt_i="17229" txt_f="17482">). The Kujala score improved by 12.8 points among the 17 patients who had at least one abnormality and who had surgical procedures owing to their abnormalities, and by 9 points among those who had abnormalities, but did not have any surgical procedure (</offsets><italic><offsets xml_i="26959" xml_f="26961" txt_i="17482" txt_f="17484">N </offsets></italic><offsets xml_i="26970" xml_f="26975" txt_i="17484" txt_f="17489">= 5).</offsets></p><table-wrap position="float" id="T4"><label><offsets xml_i="27023" xml_f="27030" txt_i="17490" txt_f="17497">Table 4</offsets></label><caption><p><offsets xml_i="27050" xml_f="27135" txt_i="17497" txt_f="17582">Arthroscopy findings and treatment procedures among patients in the arthroscopy group</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td align="center" colspan="3"><offsets xml_i="27255" xml_f="27267" txt_i="17586" txt_f="17598">Kujala score</offsets></td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td align="left"><offsets xml_i="27364" xml_f="27384" txt_i="17603" txt_f="17623">Arthroscopy findings</offsets></td><td align="left"><offsets xml_i="27406" xml_f="27448" txt_i="17624" txt_f="17666">Number of arthroscopy findings in 28 knees</offsets></td><td align="left"><offsets xml_i="27470" xml_f="27490" txt_i="17667" txt_f="17687">Treatment procedures</offsets></td><td align="left"><offsets xml_i="27512" xml_f="27534" txt_i="17688" txt_f="17710">at baseline, mean (SD)</offsets></td><td align="left"><offsets xml_i="27556" xml_f="27587" txt_i="17711" txt_f="17742">at 9-month follow-up, mean (SD)</offsets></td><td align="left"><offsets xml_i="27609" xml_f="27629" txt_i="17743" txt_f="17763">mean change (95% CI)</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="27675" xml_f="27720" txt_i="17764" txt_f="17809">Articular cartilage lesion; no other findings</offsets></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><offsets xml_i="27796" xml_f="27804" txt_i="17815" txt_f="17823"> Grade I</offsets></td><td align="left"><offsets xml_i="27826" xml_f="27827" txt_i="17824" txt_f="17825">1</offsets></td><td align="left"><offsets xml_i="27849" xml_f="27861" txt_i="17826" txt_f="17838">No treatment</offsets></td><td align="left"><offsets xml_i="27883" xml_f="27887" txt_i="17839" txt_f="17843">52.0</offsets></td><td align="left"><offsets xml_i="27909" xml_f="27913" txt_i="17844" txt_f="17848">58.0</offsets></td><td align="left"><offsets xml_i="27935" xml_f="27938" txt_i="17849" txt_f="17852">6.0</offsets></td></tr><tr><td align="left"><offsets xml_i="27969" xml_f="27978" txt_i="17853" txt_f="17862"> Grade II</offsets></td><td align="left"><offsets xml_i="28000" xml_f="28001" txt_i="17863" txt_f="17864">4</offsets></td><td align="left"><offsets xml_i="28023" xml_f="28035" txt_i="17865" txt_f="17877">No treatment</offsets></td><td align="left"><offsets xml_i="28057" xml_f="28068" txt_i="17878" txt_f="17889">68.0 (11.1)</offsets></td><td align="left"><offsets xml_i="28090" xml_f="28101" txt_i="17890" txt_f="17901">86.3 (11.0)</offsets><sup><offsets xml_i="28106" xml_f="28107" txt_i="17901" txt_f="17902">1</offsets></sup></td><td align="left"><offsets xml_i="28135" xml_f="28153" txt_i="17903" txt_f="17921">14.8 (9.5 to 20.0)</offsets><sup><offsets xml_i="28158" xml_f="28159" txt_i="17921" txt_f="17922">1</offsets></sup></td></tr><tr><td align="left"><offsets xml_i="28196" xml_f="28206" txt_i="17923" txt_f="17933"> Grade III</offsets></td><td align="left"><offsets xml_i="28228" xml_f="28229" txt_i="17934" txt_f="17935">8</offsets></td><td align="left"><offsets xml_i="28251" xml_f="28258" txt_i="17936" txt_f="17943">Shaving</offsets></td><td align="left"><offsets xml_i="28280" xml_f="28291" txt_i="17944" txt_f="17955">66.1 (13.0)</offsets></td><td align="left"><offsets xml_i="28313" xml_f="28324" txt_i="17956" txt_f="17967">82.0 (12.5)</offsets></td><td align="left"><offsets xml_i="28346" xml_f="28364" txt_i="17968" txt_f="17986">15.9 (8.7 to 23.0)</offsets></td></tr><tr><td align="left"><offsets xml_i="28395" xml_f="28404" txt_i="17987" txt_f="17996"> Grade IV</offsets></td><td align="left"><offsets xml_i="28426" xml_f="28427" txt_i="17997" txt_f="17998">1</offsets></td><td align="left"><offsets xml_i="28449" xml_f="28456" txt_i="17999" txt_f="18006">Shaving</offsets></td><td align="left"><offsets xml_i="28478" xml_f="28482" txt_i="18007" txt_f="18011">51.0</offsets></td><td align="left"><offsets xml_i="28504" xml_f="28508" txt_i="18012" txt_f="18016">59.0</offsets></td><td align="left"><offsets xml_i="28530" xml_f="28533" txt_i="18017" txt_f="18020">8.0</offsets></td></tr><tr><td align="left"><offsets xml_i="28564" xml_f="28606" txt_i="18021" txt_f="18063">Inflamed/scarred plicae; no other findings</offsets></td><td align="left"><offsets xml_i="28628" xml_f="28629" txt_i="18064" txt_f="18065">4</offsets></td><td align="left"><offsets xml_i="28651" xml_f="28660" txt_i="18066" txt_f="18075">Resection</offsets></td><td align="left"><offsets xml_i="28682" xml_f="28693" txt_i="18076" txt_f="18087">73.0 (10.1)</offsets></td><td align="left"><offsets xml_i="28715" xml_f="28725" txt_i="18088" txt_f="18098">79.8 (8.8)</offsets></td><td align="left"><offsets xml_i="28747" xml_f="28766" txt_i="18099" txt_f="18118">6.8 (-11.5 to 25.0)</offsets></td></tr><tr><td align="left"><offsets xml_i="28797" xml_f="28831" txt_i="18119" txt_f="18153">Meniscal lesion; no other findings</offsets></td><td align="left"><offsets xml_i="28853" xml_f="28854" txt_i="18154" txt_f="18155">1</offsets></td><td align="left"><offsets xml_i="28876" xml_f="28893" txt_i="18156" txt_f="18173">Partial resection</offsets></td><td align="left"><offsets xml_i="28915" xml_f="28919" txt_i="18174" txt_f="18178">72.0</offsets></td><td align="left"><offsets xml_i="28941" xml_f="28945" txt_i="18179" txt_f="18183">52.0</offsets></td><td align="left"><offsets xml_i="28967" xml_f="28972" txt_i="18184" txt_f="18189">-20.0</offsets></td></tr><tr><td align="left"><offsets xml_i="29003" xml_f="29042" txt_i="18190" txt_f="18229">Patellar subluxation; no other findings</offsets></td><td align="left"><offsets xml_i="29064" xml_f="29065" txt_i="18230" txt_f="18231">1</offsets></td><td align="left"><offsets xml_i="29087" xml_f="29099" txt_i="18232" txt_f="18244">No treatment</offsets></td><td align="left"><offsets xml_i="29121" xml_f="29125" txt_i="18245" txt_f="18249">71.0</offsets></td><td align="left"><offsets xml_i="29147" xml_f="29151" txt_i="18250" txt_f="18254">66.0</offsets></td><td align="left"><offsets xml_i="29173" xml_f="29177" txt_i="18255" txt_f="18259">-5.0</offsets></td></tr><tr><td align="left"><offsets xml_i="29208" xml_f="29251" txt_i="18260" txt_f="18303">Patellofemoral dysplasia; no other findings</offsets></td><td align="left"><offsets xml_i="29273" xml_f="29274" txt_i="18304" txt_f="18305">1</offsets></td><td align="left"><offsets xml_i="29296" xml_f="29322" txt_i="18306" txt_f="18332">Lateral capsular discision</offsets></td><td align="left"><offsets xml_i="29344" xml_f="29348" txt_i="18333" txt_f="18337">74.0</offsets></td><td align="left"><offsets xml_i="29370" xml_f="29374" txt_i="18338" txt_f="18342">98.0</offsets></td><td align="left"><offsets xml_i="29396" xml_f="29400" txt_i="18343" txt_f="18347">24.0</offsets></td></tr><tr><td align="left"><offsets xml_i="29431" xml_f="29485" txt_i="18348" txt_f="18402">Articular cartilage lesion and inflamed/scarred plicae</offsets></td><td align="left"><offsets xml_i="29507" xml_f="29508" txt_i="18403" txt_f="18404">1</offsets></td><td align="left"><offsets xml_i="29530" xml_f="29565" txt_i="18405" txt_f="18440">Shaving and plica partial resection</offsets></td><td align="left"><offsets xml_i="29587" xml_f="29591" txt_i="18441" txt_f="18445">66.0</offsets></td><td align="left"><offsets xml_i="29613" xml_f="29617" txt_i="18446" txt_f="18450">93.0</offsets></td><td align="left"><offsets xml_i="29639" xml_f="29643" txt_i="18451" txt_f="18455">27.0</offsets></td></tr><tr><td align="left"><offsets xml_i="29674" xml_f="29720" txt_i="18456" txt_f="18502">Articular cartilage lesion and meniscal lesion</offsets></td><td align="left"><offsets xml_i="29742" xml_f="29743" txt_i="18503" txt_f="18504">1</offsets></td><td align="left"><offsets xml_i="29765" xml_f="29803" txt_i="18505" txt_f="18543">Shaving and meniscal partial resection</offsets></td><td align="left"><offsets xml_i="29825" xml_f="29829" txt_i="18544" txt_f="18548">74.0</offsets></td><td align="left"><offsets xml_i="29851" xml_f="29856" txt_i="18549" txt_f="18554">100.0</offsets></td><td align="left"><offsets xml_i="29878" xml_f="29882" txt_i="18555" txt_f="18559">26.0</offsets></td></tr><tr><td align="left"><offsets xml_i="29913" xml_f="29928" txt_i="18560" txt_f="18575">Normal findings</offsets></td><td align="left"><offsets xml_i="29950" xml_f="29951" txt_i="18576" txt_f="18577">5</offsets></td><td align="left"><offsets xml_i="29973" xml_f="29985" txt_i="18578" txt_f="18590">No treatment</offsets></td><td align="left"><offsets xml_i="30007" xml_f="30018" txt_i="18591" txt_f="18602">72.2 (11.7)</offsets></td><td align="left"><offsets xml_i="30040" xml_f="30050" txt_i="18603" txt_f="18613">89.2 (9.5)</offsets></td><td align="left"><offsets xml_i="30072" xml_f="30090" txt_i="18614" txt_f="18632">17.0 (1.6 to 32.4)</offsets></td></tr></tbody></table><table-wrap-foot><p><sup><offsets xml_i="30141" xml_f="30142" txt_i="18633" txt_f="18634">1</offsets></sup><offsets xml_i="30148" xml_f="30192" txt_i="18634" txt_f="18678">N = 3; one patient lost to 9-month follow-up</offsets></p></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="30245" xml_f="30281" txt_i="18680" txt_f="18716">Costs and use of healthcare services</offsets></title><p><offsets xml_i="30292" xml_f="30298" txt_i="18717" txt_f="18723">Table </offsets><xref ref-type="table" rid="T5"><offsets xml_i="30330" xml_f="30331" txt_i="18723" txt_f="18724">5</offsets></xref><offsets xml_i="30338" xml_f="30593" txt_i="18724" txt_f="18979"> shows the mean direct healthcare costs and use of healthcare services per patient for PFPS during the intervention and the follow-up period. The mean difference per patient in total direct healthcare costs between the groups was €901 (95% CI 714 – 1095, </offsets><italic><offsets xml_i="30601" xml_f="30603" txt_i="18979" txt_f="18981">p </offsets></italic><offsets xml_i="30612" xml_f="30723" txt_i="18981" txt_f="19089">&lt; 0.001). The mean number of sick leave days was 8.7 in the arthroscopy group and 1.4 in the control group (</offsets><italic><offsets xml_i="30731" xml_f="30733" txt_i="19089" txt_f="19091">p </offsets></italic><offsets xml_i="30742" xml_f="30754" txt_i="19091" txt_f="19100">&lt; 0.001).</offsets></p><table-wrap position="float" id="T5"><label><offsets xml_i="30802" xml_f="30809" txt_i="19101" txt_f="19108">Table 5</offsets></label><caption><p><offsets xml_i="30829" xml_f="30973" txt_i="19108" txt_f="19252">Costs and use of healthcare services among patients with PFPS in the arthroscopy and control groups during the intervention and follow-up period</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td align="center" colspan="2"><offsets xml_i="31084" xml_f="31118" txt_i="19255" txt_f="19289">Number of visits, mean per patient</offsets></td><td align="center" colspan="2"><offsets xml_i="31154" xml_f="31199" txt_i="19290" txt_f="19335">Direct healthcare costs (€), mean per patient</offsets></td></tr><tr><td align="left"><offsets xml_i="31230" xml_f="31249" txt_i="19336" txt_f="19355">Type of utilization</offsets></td><td align="left"><offsets xml_i="31271" xml_f="31285" txt_i="19356" txt_f="19370">Cost/visit (€)</offsets></td><td align="left"><offsets xml_i="31307" xml_f="31324" txt_i="19371" txt_f="19388">Arthroscopy group</offsets></td><td align="left"><offsets xml_i="31346" xml_f="31359" txt_i="19389" txt_f="19402">Control group</offsets></td><td align="left"><offsets xml_i="31381" xml_f="31398" txt_i="19403" txt_f="19420">Arthroscopy group</offsets></td><td align="left"><offsets xml_i="31420" xml_f="31433" txt_i="19421" txt_f="19434">Control group</offsets></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="31479" xml_f="31502" txt_i="19435" txt_f="19458">Medical specialist care</offsets></td><td align="left"><offsets xml_i="31524" xml_f="31530" txt_i="19459" txt_f="19465">174.50</offsets></td><td align="left"><offsets xml_i="31552" xml_f="31556" txt_i="19466" txt_f="19470">1.18</offsets></td><td align="left"><offsets xml_i="31578" xml_f="31582" txt_i="19471" txt_f="19475">1.29</offsets></td><td align="left"><offsets xml_i="31604" xml_f="31610" txt_i="19476" txt_f="19482">205.90</offsets></td><td align="left"><offsets xml_i="31632" xml_f="31638" txt_i="19483" txt_f="19489">225.10</offsets></td></tr><tr><td align="left"><offsets xml_i="31669" xml_f="31685" txt_i="19490" txt_f="19506">Knee arthroscopy</offsets></td><td align="left"><offsets xml_i="31707" xml_f="31714" txt_i="19507" txt_f="19514">1039.00</offsets></td><td align="left"><offsets xml_i="31736" xml_f="31740" txt_i="19515" txt_f="19519">1.00</offsets></td><td align="left"><offsets xml_i="31762" xml_f="31766" txt_i="19520" txt_f="19524">0.11</offsets></td><td align="left"><offsets xml_i="31788" xml_f="31795" txt_i="19525" txt_f="19532">1039.00</offsets></td><td align="left"><offsets xml_i="31817" xml_f="31823" txt_i="19533" txt_f="19539">114.30</offsets></td></tr><tr><td align="left"><offsets xml_i="31854" xml_f="31899" txt_i="19540" txt_f="19585">Physiotherapy (session of 30 minutes maximum)</offsets></td><td align="left"><offsets xml_i="31921" xml_f="31926" txt_i="19586" txt_f="19591">33.50</offsets></td><td align="left"><offsets xml_i="31948" xml_f="31952" txt_i="19592" txt_f="19596">2.11</offsets></td><td align="left"><offsets xml_i="31974" xml_f="31978" txt_i="19597" txt_f="19601">2.25</offsets></td><td align="left"><offsets xml_i="32000" xml_f="32005" txt_i="19602" txt_f="19607">70.70</offsets></td><td align="left"><offsets xml_i="32027" xml_f="32032" txt_i="19608" txt_f="19613">75.40</offsets></td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left"><offsets xml_i="32102" xml_f="32153" txt_i="19615" txt_f="19666">Total direct healthcare costs (€), mean per patient</offsets></td><td></td><td></td><td></td><td align="left"><offsets xml_i="32202" xml_f="32209" txt_i="19670" txt_f="19677">1315.60</offsets></td><td align="left"><offsets xml_i="32231" xml_f="32237" txt_i="19678" txt_f="19684">414.80</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="32283" xml_f="32438" txt_i="19685" txt_f="19840">The number of visits includes baseline visit by the orthopedic surgeon and number of visits for the allocated intervention (arthroscopy and physiotherapy).</offsets></p></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="32491" xml_f="32518" txt_i="19842" txt_f="19869">Twenty-four-month follow-up</offsets></title><p><offsets xml_i="32529" xml_f="33055" txt_i="19870" txt_f="20396">Twenty-five (89%) patients from the arthroscopy group and 23 (82%) patients from the control group answered the 24-month follow-up questionnaire. The mean improvement according to the Kujala score was maintained at the 24-month follow-up in both the arthroscopy group and control group (mean scores 12.5 and 9.4, respectively). No difference in the mean change in the Kujala score between randomization and the 24-month follow-up was found (baseline-adjusted difference arthroscopy versus controls was 2.8; 95% CI -4.2 – 9.9, </offsets><italic><offsets xml_i="33063" xml_f="33065" txt_i="20396" txt_f="20398">p </offsets></italic><offsets xml_i="33074" xml_f="33082" txt_i="20398" txt_f="20406">= 0.42).</offsets></p></sec></sec><sec><title><offsets xml_i="33110" xml_f="33120" txt_i="20409" txt_f="20419">Discussion</offsets></title><p><offsets xml_i="33131" xml_f="33603" txt_i="20420" txt_f="20892">Our study shows that arthroscopy did not provide any overall additional advantage for chronic PFPS patients when provided in addition to the training program. Our economic analysis showed that the direct healthcare costs were higher in the arthroscopy group compared with the control group. Moreover, the higher numbers of days on sick leave among the patients in the arthroscopy group indicate that the indirect healthcare costs were also higher in the arthroscopy group.</offsets></p><p><offsets xml_i="33610" xml_f="33717" txt_i="20893" txt_f="21000">Our arthroscopy procedure was based on recommendations on the etiology and arthroscopic treatment of PFPS [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="33748" xml_f="33749" txt_i="21000" txt_f="21001">2</offsets></xref><offsets xml_i="33756" xml_f="34308" txt_i="21001" txt_f="21553">]. Despite a statistically insignificant trend towards a baseline difference between the groups in the Kujala score, it is likely that abnormalities in the patellofemoral joint were evenly distributed between our arthroscopy and control groups. Furthermore, when investigating the effects of treatment between the groups, we adjusted our results with the baseline values. Also, in the arthroscopy group, the patients with abnormalities who were operated on using recommended surgical procedures did not show greater improvement than the other patients.</offsets></p><p><offsets xml_i="34315" xml_f="34802" txt_i="21554" txt_f="22041">Two patients were shown to have meniscal pathology in arthroscopy. However, both of these patients reported anterior knee pain symptoms at the baseline examination. It is known that some patients with meniscus problems report anterior knee pain symptoms, but we cannot be sure whether these symptoms were in fact due to meniscus pathology in our subjects. These patients were treated according our preliminary pre-determined guidelines, which followed generally accepted recommendations.</offsets></p><p><offsets xml_i="34809" xml_f="35325" txt_i="22042" txt_f="22558">We do not know whether the number of abnormalities seen in our arthroscopy group is higher than might be found in a non-symptomatic population. Interestingly, the mean improvement was somewhat better among the patients whose arthroscopic findings were normal. The mechanism responsible for the effectiveness of the treatment among these patients is unknown. Patients with chronic pain expect aggressive treatment and a patient's expectations may influence the clinical outcome independently of the treatment itself [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="35357" xml_f="35359" txt_i="22558" txt_f="22560">13</offsets></xref><offsets xml_i="35366" xml_f="35415" txt_i="22560" txt_f="22609">]. Arthroscopy itself may have a placebo effect [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="35447" xml_f="35449" txt_i="22609" txt_f="22611">14</offsets></xref><offsets xml_i="35456" xml_f="35541" txt_i="22611" txt_f="22696">]. This possible placebo effect does not change the conclusions drawn from our study.</offsets></p><p><offsets xml_i="35548" xml_f="35930" txt_i="22697" txt_f="23079">Only patients with symptoms of at least 6 months duration were included in our study and after the follow-up one-fifth of these patients reported no improvement compared with the baseline situation. Although PFPS is usually a non-progrediating condition, our result is in line with earlier findings that, despite adequate treatment, some patients with PFPS have long-term symptoms [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="35962" xml_f="35964" txt_i="23079" txt_f="23081">15</offsets></xref><offsets xml_i="35971" xml_f="36155" txt_i="23081" txt_f="23265">]. Although different stage cartilage lesions seem to be quite common among patients with PFPS, the association between cartilage lesion and symptoms is usually considered to be weak [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="36186" xml_f="36187" txt_i="23265" txt_f="23266">1</offsets></xref><offsets xml_i="36194" xml_f="36195" txt_i="23266" txt_f="23267">,</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="36227" xml_f="36229" txt_i="23267" txt_f="23269">16</offsets></xref><offsets xml_i="36236" xml_f="36374" txt_i="23269" txt_f="23407">]. In our previous study on PFPS patients, only severe, possibly pre-arthrotic, cartilage injury predicted persistent long-term symptoms [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="36406" xml_f="36408" txt_i="23407" txt_f="23409">12</offsets></xref><offsets xml_i="36415" xml_f="36530" txt_i="23409" txt_f="23524">]. In the present study only one patient had a stage IV cartilage lesion and his Kujala score improved by 8 points.</offsets></p><p><offsets xml_i="36537" xml_f="37286" txt_i="23525" txt_f="24274">While our primary aim was to investigate the possible additional benefit of knee arthroscopy among patients with PFPS, an exercise program consisting of simple lower-limb stretching and strengthening exercises was used as a generally accepted treatment to improve the adherence to our arthroscopy versus no-arthroscopy study design. As our patients had experienced prolonged knee symptoms, it would have been difficult and perhaps unethical to use a no-treatment control group. Also, the number of withdrawals and dropouts would have been higher among patients without any treatment. Although three patients from the control group insisted on an arthroscopy during the follow-up, their outcome was no better than that reported by the other controls.</offsets></p><p><offsets xml_i="37293" xml_f="37886" txt_i="24275" txt_f="24868">The fairly high mean weekly exercise frequency indicated good treatment compliance in both groups. A speculative, alternative interpretation of our results is that exercise was effective both with and without the addition of arthroscopy. It should be emphasized that the primary aim was not to investigate the effectiveness of exercise therapy in patients with PFPS. In fact, we found no association between frequency of weekly exercise and improvement (data not shown). Despite that, our results are in line with the earlier view that exercise therapy may be an effective treatment for PFPS [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="37917" xml_f="37918" txt_i="24868" txt_f="24869">4</offsets></xref><offsets xml_i="37925" xml_f="37927" txt_i="24869" txt_f="24871">].</offsets></p><p><offsets xml_i="37934" xml_f="38547" txt_i="24872" txt_f="25485">Competitive athletes, who may have had pain syndrome related to extreme loading and perhaps not be willing to follow the present treatment protocols, were excluded from the study. Also, patients younger than 18 and those over 40 years of age were excluded. Our results are valid for young adults who do not participate in competitive sports. Our study shows that an unselected group of chronic PFPS patients received no benefit from arthroscopy in addition to exercise therapy. The study does not show whether there are any subgroups of PFPS patients who would benefit from arthroscopy. However, this is possible.</offsets></p><p><offsets xml_i="38554" xml_f="38778" txt_i="25486" txt_f="25710">Although our primary end-point was at 9 months, as we wished to avoid many of the random factors, which can influence longer follow-ups, we also collected data at 24 months. Extending the follow-up did not change the result.</offsets></p><p><offsets xml_i="38785" xml_f="38994" txt_i="25711" txt_f="25920">In conclusion, on the basis of our randomized study, which was planned using available knowledge on the diagnosis and methods of treating PFPS, arthroscopy cannot be recommended for patients with chronic PFPS.</offsets></p></sec><sec><title><offsets xml_i="39016" xml_f="39035" txt_i="25922" txt_f="25941">Competing interests</offsets></title><p><offsets xml_i="39046" xml_f="39106" txt_i="25942" txt_f="26002">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="39128" xml_f="39150" txt_i="26004" txt_f="26026">Authors' contributions</offsets></title><p><offsets xml_i="39161" xml_f="40029" txt_i="26027" txt_f="26895">JAK participated in all parts of the study, including the design and coordination of the study, data collection and writing of the manuscript. DS performed the baseline clinical examinations and participated in the design of the study, data collection and writing of the manuscript. AH and JS performed the arthroscopies and participated in the design of the study, data collection and writing of the manuscript. KH participated in the design of the study, data collection and writing of the manuscript. SS participated in the design of the study, data collection and writing of the manuscript. AM contributed to planning the study and writing the manuscript. UMK was the research leader in charge, and he participated in the design of the study, obtaining funding, data analysis and writing of the manuscript. All of the authors saw and approved the final manuscript.</offsets></p></sec><sec><title><offsets xml_i="40051" xml_f="40074" txt_i="26897" txt_f="26920">Pre-publication history</offsets></title><p><offsets xml_i="40085" xml_f="40149" txt_i="26921" txt_f="26985">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/5/38/prepub"></ext-link></p></sec><sec sec-type="supplementary-material"><title><offsets xml_i="40317" xml_f="40339" txt_i="26988" txt_f="27010">Supplementary Material</offsets></title><supplementary-material content-type="local-data" id="S1"><caption><title><offsets xml_i="40421" xml_f="40438" txt_i="27011" txt_f="27028">Additional File 1</offsets></title><p><offsets xml_i="40449" xml_f="40505" txt_i="27029" txt_f="27085">The 8-week home exercise program for patients with PFPS.</offsets></p></caption><media xlink:href="1741-7015-5-38-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p><offsets xml_i="40615" xml_f="40634" txt_i="27086" txt_f="27105">Click here for file</offsets></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title><offsets xml_i="40755" xml_f="40772" txt_i="27106" txt_f="27123">Additional File 2</offsets></title><p><offsets xml_i="40783" xml_f="40800" txt_i="27124" txt_f="27141">The Kujala score.</offsets></p></caption><media xlink:href="1741-7015-5-38-S2.pdf" mimetype="application" mime-subtype="pdf"><caption><p><offsets xml_i="40910" xml_f="40929" txt_i="27142" txt_f="27161">Click here for file</offsets></p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We wish to thank the physicians, physical therapists and nurses at the ORTON Orthopaedic Hospital and at the hospitals of the Hospital District of Helsinki and Uusimaa for their contributions to the study. This research was supported by a grant from The Social Insurance Institution of Finland.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Ficat</surname><given-names>R</given-names></name><name><surname>Hungerford</surname><given-names>D</given-names></name></person-group><source>Disorders of the patello-femoral joint</source><year>1977</year><publisher-name>Paris: Masson</publisher-name></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>WR</given-names></name></person-group><article-title>Anterior knee pain: diagnosis and treatment</article-title><source>J Am Acad Orthop Surg</source><year>2005</year><volume>13</volume><fpage>534</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">16330515</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fulkerson</surname><given-names>JP</given-names></name></person-group><article-title>Diagnosis and treatment of patients with patellofemoral pain</article-title><source>Am J Sports Med</source><year>2002</year><volume>30</volume><fpage>447</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">12016090</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heintjes</surname><given-names>E</given-names></name><name><surname>Berger</surname><given-names>MY</given-names></name><name><surname>Bierma-Zeinstra</surname><given-names>SM</given-names></name><name><surname>Bernsen</surname><given-names>RM</given-names></name><name><surname>Verhaar</surname><given-names>JA</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group><article-title>Exercise therapy for patellofemoral pain syndrome</article-title><source>Cochrane Database Syst Rev</source><year>2003</year><fpage>CD003472</fpage><pub-id pub-id-type="pmid">14583980</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Neill</surname><given-names>DB</given-names></name></person-group><article-title>Open lateral retinacular lengthening compared with arthroscopic release. A prospective, randomized outcome study</article-title><source>J Bone Joint Surg Am</source><year>1997</year><volume>79</volume><fpage>1759</fpage><lpage>1769</lpage><pub-id pub-id-type="pmid">9409789</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raunest</surname><given-names>J</given-names></name><name><surname>Lohnert</surname><given-names>J</given-names></name></person-group><article-title>Arthroscopic cartilage debridement by excimer laser in chondromalacia of the knee joint. A prospective randomized clinical study</article-title><source>Arch Orthop Trauma Surg</source><year>1990</year><volume>109</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">2189483</pub-id><pub-id pub-id-type="doi">10.1007/BF00440577</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Outerbridge</surname><given-names>RE</given-names></name></person-group><article-title>The etiology of chondromalacia patellae</article-title><source>J Bone Joint Surg Br</source><year>1961</year><volume>43-B</volume><fpage>752</fpage><lpage>757</lpage><pub-id pub-id-type="pmid">14038135</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kujala</surname><given-names>UM</given-names></name><name><surname>Jaakkola</surname><given-names>LH</given-names></name><name><surname>Koskinen</surname><given-names>SK</given-names></name><name><surname>Taimela</surname><given-names>S</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name><name><surname>Nelimarkka</surname><given-names>O</given-names></name></person-group><article-title>Scoring of patellofemoral disorders</article-title><source>Arthroscopy</source><year>1993</year><volume>9</volume><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8461073</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>Bennell</surname><given-names>KL</given-names></name><name><surname>Cowan</surname><given-names>SM</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><article-title>Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid?</article-title><source>Arch Phys Med Rehabil</source><year>2004</year><volume>85</volume><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">15129407</pub-id><pub-id pub-id-type="doi">10.1016/S0003-9993(03)00613-0</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennell</surname><given-names>K</given-names></name><name><surname>Bartram</surname><given-names>S</given-names></name><name><surname>Crossley</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><article-title>Outcome measures in patellofemoral pain syndrome: test retest reliability and inter-relationships</article-title><source>Phys Ther Sport</source><year>2000</year><fpage>32</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1054/ptsp.2000.0009</pub-id></citation></ref><ref id="B11"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hujanen</surname><given-names>T</given-names></name></person-group><source>Guidelines for Health Care Unit Costs in Finland 2001 (in Finnish: Terveydenhuollon yksikkökustannukset Suomessa vuonna 2001)</source><year>2003</year><publisher-name>National Research and Development Centre for Welfare and Health</publisher-name></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kettunen</surname><given-names>JA</given-names></name><name><surname>Visuri</surname><given-names>T</given-names></name><name><surname>Harilainen</surname><given-names>A</given-names></name><name><surname>Sandelin</surname><given-names>J</given-names></name><name><surname>Kujala</surname><given-names>UM</given-names></name></person-group><article-title>Primary cartilage lesions and outcome among subjects with patellofemoral pain syndrome</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2005</year><volume>13</volume><fpage>131</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">15756617</pub-id><pub-id pub-id-type="doi">10.1007/s00167-004-0555-z</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalauokalani</surname><given-names>D</given-names></name><name><surname>Cherkin</surname><given-names>DC</given-names></name><name><surname>Sherman</surname><given-names>KJ</given-names></name><name><surname>Koepsell</surname><given-names>TD</given-names></name><name><surname>Deyo</surname><given-names>RA</given-names></name></person-group><article-title>Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects</article-title><source>Spine</source><year>2001</year><volume>26</volume><fpage>1418</fpage><lpage>1424</lpage><pub-id pub-id-type="pmid">11458142</pub-id><pub-id pub-id-type="doi">10.1097/00007632-200107010-00005</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname><given-names>JB</given-names></name><name><surname>O'Malley</surname><given-names>K</given-names></name><name><surname>Petersen</surname><given-names>NJ</given-names></name><name><surname>Menke</surname><given-names>TJ</given-names></name><name><surname>Brody</surname><given-names>BA</given-names></name><name><surname>Kuykendall</surname><given-names>DH</given-names></name><name><surname>Hollingsworth</surname><given-names>JC</given-names></name><name><surname>Ashton</surname><given-names>CM</given-names></name><name><surname>Wray</surname><given-names>NP</given-names></name></person-group><article-title>A controlled trial of arthroscopic surgery for osteoarthritis of the knee</article-title><source>N Engl J Med</source><year>2002</year><volume>347</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">12110735</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa013259</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannus</surname><given-names>P</given-names></name><name><surname>Natri</surname><given-names>A</given-names></name><name><surname>Paakkala</surname><given-names>T</given-names></name><name><surname>Jarvinen</surname><given-names>M</given-names></name></person-group><article-title>An outcome study of chronic patellofemoral pain syndrome. Seven-year follow-up of patients in a randomized, controlled trial</article-title><source>J Bone Joint Surg Am</source><year>1999</year><volume>81</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">10199273</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stougård</surname><given-names>J</given-names></name></person-group><article-title>Chondromalacia of the patella</article-title><source>Acta Orthop Scand</source><year>1975</year><volume>46</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">1180029</pub-id></citation></ref></ref-list></back></article>